CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
53.15
+0.53 (1.01%)
At close: Jan 21, 2025, 4:00 PM
53.24
+0.09 (0.17%)
After-hours: Jan 21, 2025, 7:46 PM EST
CVS Health Market Cap
CVS Health has a market cap or net worth of $66.88 billion as of January 21, 2025. Its market cap has decreased by -35.74% in one year.
Market Cap
66.88B
Enterprise Value
139.91B
1-Year Change
-35.74%
Ranking
Category
Stock Price
$53.15
Market Cap Chart
Since December 1, 1998, CVS Health's market cap has increased from $19.55B to $66.88B, an increase of 242.15%. That is a compound annual growth rate of 4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 66.22B | 17.22% |
| Dec 31, 2024 | 56.49B | -44.41% |
| Dec 29, 2023 | 101.61B | -17.02% |
| Dec 30, 2022 | 122.45B | -10.08% |
| Dec 31, 2021 | 136.18B | 52.33% |
| Dec 31, 2020 | 89.40B | -7.50% |
| Dec 31, 2019 | 96.65B | 44.79% |
| Dec 31, 2018 | 66.75B | -9.11% |
| Dec 29, 2017 | 73.44B | -12.73% |
| Dec 30, 2016 | 84.15B | -22.27% |
| Dec 31, 2015 | 108.26B | -1.94% |
| Dec 31, 2014 | 110.41B | 29.61% |
| Dec 31, 2013 | 85.19B | 41.32% |
| Dec 31, 2012 | 60.28B | 13.56% |
| Dec 30, 2011 | 53.08B | 12.35% |
| Dec 31, 2010 | 47.25B | 3.99% |
| Dec 31, 2009 | 45.43B | 10.07% |
| Dec 31, 2008 | 41.28B | -29.69% |
| Dec 31, 2007 | 58.71B | 130.61% |
| Dec 29, 2006 | 25.46B | 18.34% |
| Dec 30, 2005 | 21.51B | 19.30% |
| Dec 31, 2004 | 18.03B | 26.40% |
| Dec 31, 2003 | 14.27B | 45.39% |
| Dec 31, 2002 | 9.81B | -15.18% |
| Dec 31, 2001 | 11.57B | -50.74% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |